Cargando…
Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016
BACKGROUND: Anticoagulation among patients with cancer and atrial fibrillation is challenging due to elevated risk of bleeding and stroke. We characterized use of oral anticoagulants among patients with cancer and non‐valvular atrial fibrillation (NVAF). METHODS: We used Surveillance, Epidemiology,...
Autores principales: | Ardeshirrouhanifard, Shirin, An, Huijun, Goyal, Ravi K., Raji, Mukaila A., Segal, Jodi B., Alexander, G. Caleb, Mehta, Hemalkumar B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302858/ https://www.ncbi.nlm.nih.gov/pubmed/35364622 http://dx.doi.org/10.1002/phar.2679 |
Ejemplares similares
-
Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation
por: Zhou, Meijia, et al.
Publicado: (2015) -
TRENDS IN OPIOID USE IN LONG-TERM CARE NURSING HOME RESIDENTS WITH DEMENTIA
por: Mehta, Hemalkumar B, et al.
Publicado: (2019) -
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis
por: Mehta, Hemalkumar B, et al.
Publicado: (2020) -
Safety and effectiveness of apixaban versus warfarin for acute venous thromboembolism in patients with end‐stage kidney disease: A national cohort study
por: Ellenbogen, Michael I., et al.
Publicado: (2022) -
Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)